{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:25:43Z","timestamp":1786947943178,"version":"build-2736575974"},"reference-count":267,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0501900 & 2023ZD0501904 & 2023ZD0501905"],"award-info":[{"award-number":["2023ZD0501900 & 2023ZD0501904 & 2023ZD0501905"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2023LSW023"],"award-info":[{"award-number":["ZR2023LSW023"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373044"],"award-info":[{"award-number":["82373044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02278-1","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:45:11Z","timestamp":1786193111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neural regulation in lung cancer: from mechanisms to new therapeutic perspectives"],"prefix":"10.1007","volume":"26","author":[{"given":"Junfeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingrui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuankun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"2278_CR1","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.2147\/IJN.S432839","volume":"18","author":"S Aryal","year":"2023","unstructured":"Aryal S, et al. Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches. Int J Nanomed. 2023;18:7865\u201388.","journal-title":"Int J Nanomed"},{"key":"2278_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052049","author":"B Smolarz","year":"2025","unstructured":"Smolarz B, et al. Lung cancer\u2014epidemiology, pathogenesis, treatment and molecular aspect (review of literature). Int J Mol Sci. 2025;26(5):2049. https:\/\/doi.org\/10.3390\/ijms26052049","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2278_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"2278_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01407-z","author":"N Xing","year":"2023","unstructured":"Xing N, et al. Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy. Cell Death Discov. 2023;9(1):110. https:\/\/doi.org\/10.1038\/s41420-023-01407-z","journal-title":"Cell Death Discov"},{"key":"2278_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2527752","author":"Y Xu","year":"2025","unstructured":"Xu Y, et al. Nanomedicine initiates ferroptosis for enhanced lung cancer therapy. Drug Deliv. 2025 ;32(1):2527752. https:\/\/doi.org\/10.1080\/10717544.2025.2527752","journal-title":"Drug Deliv"},{"key":"2278_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01332-9","author":"H Li","year":"2023","unstructured":"Li H, et al. Applications of lung cancer organoids in precision medicine: from bench to bedside. Cell Commun Signal. 2023;21(1):350. https:\/\/doi.org\/10.1186\/s12964-023-01332-9","journal-title":"Cell Commun Signal"},{"key":"2278_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420463","author":"Q Si","year":"2024","unstructured":"Si Q, et al. Photonanozyme\u2013Kras\u2013ribosome combination treatment of non-small cell lung cancer after COVID-19. Front Immunol. 2024;15:1420463 . https:\/\/doi.org\/10.3389\/fimmu.2024.1420463","journal-title":"Front Immunol"},{"issue":"5","key":"2278_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/CM9.0000000000002991","volume":"137","author":"T Barr","year":"2024","unstructured":"Barr T, et al. Recent advances and remaining challenges in lung cancer therapy. Chin Med J. 2024;137(5):533\u201346.","journal-title":"Chin Med J"},{"key":"2278_CR9","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.2147\/IJN.S281029","volume":"15","author":"S-J Yang","year":"2020","unstructured":"Yang S-J, et al. <p> The synergistic effect of hyperthermia and chemotherapy in magnetite nanomedicine-based lung cancer treatment<\/p>. Int J Nanomedicine. 2020;15:10331\u201347.","journal-title":"Int J Nanomedicine"},{"key":"2278_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1237978","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu J. Mechanism and clinical application of thymosin in the treatment of lung cancer. Front Immunol. 2023;14:1237978. https:\/\/doi.org\/10.3389\/fimmu.2023.1237978","journal-title":"Front Immunol"},{"issue":"3","key":"2278_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tem.2023.11.005","volume":"35","author":"C Mancini","year":"2024","unstructured":"Mancini C, et al. Metabolic challengers selecting tumor-persistent cells. Trends Endocrinol Metabolism. 2024;35:(3):263\u201376.","journal-title":"Trends Endocrinol Metabolism"},{"key":"2278_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217701","author":"X Xiao","year":"2025","unstructured":"Xiao X, et al. Intersection between lung cancer and neuroscience: opportunities and challenges. Cancer Lett. 2025.;621:217701 https:\/\/doi.org\/10.1016\/j.canlet.2025.217701","journal-title":"Cancer Lett"},{"issue":"13","key":"2278_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/CM9.0000000000003656","volume":"138","author":"X Wang","year":"2025","unstructured":"Wang X, et al. Cancer and neurotransmitter receptors. Chin Med J. 2025;138(13):1540\u201358.","journal-title":"Chin Med J"},{"key":"2278_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189007","author":"J Li","year":"2023","unstructured":"Li J, et al. The association between the neuroendocrine system and the tumor immune microenvironment: emerging directions for cancer immunotherapy. Biochimica et biophysica acta. Reviews on cancer. 2023;1878(6):189007. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189007","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"43","key":"2278_CR15","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-022-02479-4","volume":"41","author":"F Battaglin","year":"2022","unstructured":"Battaglin F, et al. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment. Oncogene. 2022;41(43):4769\u201378.","journal-title":"Oncogene"},{"issue":"7","key":"2278_CR16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41416-022-02132-7","volume":"128","author":"Q Geng","year":"2023","unstructured":"Geng Q, et al. Norepinephrine inhibits CD8\u2009+\u2009T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma. Br J Cancer. 2023;128(7):1223\u201335.","journal-title":"Br J Cancer"},{"key":"2278_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897356","author":"K Yang","year":"2022","unstructured":"Yang K, et al. The controversial role of IL-33 in lung cancer. Front Immunol. 2022; 13:897356. https:\/\/doi.org\/10.3389\/fimmu.2022.897356","journal-title":"Front Immunol"},{"issue":"21","key":"2278_CR18","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1158\/0008-5472.CAN-24-1779","volume":"84","author":"X Chen","year":"2024","unstructured":"Chen X, et al. Neural Circuitries between the Brain and Peripheral Solid Tumors. Cancer Res. 2024;84(21):3509\u201321.","journal-title":"Cancer Res"},{"issue":"13","key":"2278_CR19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1158\/0008-5472.CAN-24-3481","volume":"85","author":"C Liu","year":"2025","unstructured":"Liu C, et al. Chronic stress stimulates protumor macrophage polarization to propel lung cancer progression. Cancer Res. 2025;85(13):2429\u201347.","journal-title":"Cancer Res"},{"key":"2278_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04179-w","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, et al. Stress induces corticosterone-mediated CD8+ T cell exhaustion to promote non-small cell lung cancer. Cancer Immunol Immunother. 2025; 74(10):316. https:\/\/doi.org\/10.1007\/s00262-025-04179-w","journal-title":"Cancer Immunol Immunother"},{"key":"2278_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03122-8","author":"D Sun","year":"2024","unstructured":"Sun D, et al. CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN\/AKT signaling phosphorylation and neutrophil chemotaxis. J Exp Clin Cancer Res. 2024;43(1):202. https:\/\/doi.org\/10.1186\/s13046-024-03122-8","journal-title":"J Exp Clin Cancer Res"},{"key":"2278_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6614574","author":"W Ma","year":"2021","unstructured":"Ma W, et al. Salidroside suppresses the proliferation and migration of human lung cancer cells through AMPK-dependent NLRP3 inflammasome regulation. Oxid Med Cell Longev. 2021. https:\/\/doi.org\/10.1155\/2021\/6614574.","journal-title":"Oxid Med Cell Longev"},{"key":"2278_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2024.100994","author":"F Bettariga","year":"2025","unstructured":"Bettariga F, et al. Effects of short- and long-term exercise training on cancer cells in vitro: insights into the mechanistic associations. J Sport Health Sci. 2025;14:100994. https:\/\/doi.org\/10.1016\/j.jshs.2024.100994","journal-title":"J Sport Health Sci"},{"issue":"4","key":"2278_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jshs.2023.12.001","volume":"13","author":"F Bettariga","year":"2024","unstructured":"Bettariga F, et al. Suppressive effects of exercise-conditioned serum on cancer cells: A narrative review of the influence of exercise mode, volume, and intensity. J Sport Health Sci. 2024;13(4):484\u201398.","journal-title":"J Sport Health Sci"},{"key":"2278_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02640-y","author":"Q Ding","year":"2024","unstructured":"Ding Q, et al. Breathing exercises for patients with early-stage lung cancer: a meta-analysis. Syst Rev. 2024;13(1):243. https:\/\/doi.org\/10.1186\/s13643-024-02640-y","journal-title":"Syst Rev"},{"key":"2278_CR26","doi-asserted-by":"crossref","unstructured":"Ulrich CM et al. Precision Exercise Effect on Fatigue and Function in Lung Cancer Surgery. JAMA Surg, 2025;160(5):495-519.","DOI":"10.1001\/jamasurg.2025.0130"},{"key":"2278_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4938811","author":"L Han","year":"2022","unstructured":"Han L, et al. MicroRNA 101 attenuated NSCLC proliferation through IDH2\/HIF\u03b1 axis suppression in the Warburg effect. Oxid Med Cell Longev. 2022. https:\/\/doi.org\/10.1155\/2022\/4938811.","journal-title":"Oxid Med Cell Longev"},{"key":"2278_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24898-9","author":"X Tan","year":"2021","unstructured":"Tan X, et al. Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation. Nat Commun. 2021;12(1):4853. https:\/\/doi.org\/10.1038\/s41467-021-24898-9","journal-title":"Nat Commun"},{"key":"2278_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04890-x","author":"L-N Wang","year":"2022","unstructured":"Wang L-N, et al. TGF-\u03b21\/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2\/STAT3 and SHP2\/Grb2 signaling pathways. Cell Death Dis. 2022. https:\/\/doi.org\/10.1038\/s41419-022-04890-x.","journal-title":"Cell Death Dis"},{"key":"2278_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215814","author":"C Zhu","year":"2022","unstructured":"Zhu C, et al. Exercise in cancer prevention and anticancer therapy: efficacy, molecular mechanisms and clinical information. Cancer Lett. 2022;544:215814. https:\/\/doi.org\/10.1016\/j.canlet.2022.215814","journal-title":"Cancer Lett"},{"key":"2278_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02609-3","author":"R Miao","year":"2025","unstructured":"Miao R, et al. Exercise-induced lactate suppresses ccRCC via CNDP2-mediated depletion of intracellular amino acids. Cell Death Discov. 2025; 11(1):356. https:\/\/doi.org\/10.1038\/s41420-025-02609-3","journal-title":"Cell Death Discov"},{"issue":"5","key":"2278_CR32","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1097\/JS9.0000000000002323","volume":"111","author":"X Chen","year":"2025","unstructured":"Chen X, Li Z, Zhang J. A novel approach to cancer rehabilitation: assessing the influence of exercise intervention on postoperative recovery and survival rates. International journal of surgery (London, England). 2025;111(5):3373\u201385.","journal-title":"International journal of surgery (London, England)"},{"issue":"1","key":"2278_CR33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012112","volume":"3","author":"MR Picciotto","year":"2012","unstructured":"Picciotto MR, Kenny PJ. Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb Perspect Med. 2012;3(1):a012112-a012112.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2278_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112202","volume":"144","author":"R Liang","year":"2021","unstructured":"Liang R, Li X, Li W, Zhu X, Li C. DNA methylation in lung cancer patients: opening a \u201cwindow of life\u201d under precision medicine. Biomed Pharmacother. 2021;144:112202.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2278_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10654-022-00877-2","volume":"37","author":"D Petrovic","year":"2022","unstructured":"Petrovic D, et al. Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. Eur J Epidemiol. 2022;37(6):629\u201340.","journal-title":"Eur J Epidemiol"},{"key":"2278_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06301-z","author":"C Ouyang","year":"2025","unstructured":"Ouyang C, et al. Multidimensional bioinformatics perspective on smoking-linked driver genes and immune regulatory mechanisms in non-small cell lung cancer. J Transl Med. 2025; 23(1):330. https:\/\/doi.org\/10.1186\/s12967-025-06301-z","journal-title":"J Transl Med"},{"issue":"11","key":"2278_CR37","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.7150\/ijbs.73428","volume":"18","author":"T Liu","year":"2022","unstructured":"Liu T, et al. Smoke-induced SAV1 Gene Promoter Hypermethylation Disrupts YAP Negative Feedback and Promotes Malignant Progression of Non-small Cell Lung Cancer. Int J Biol Sci. 2022;18(11):4497\u2013512.","journal-title":"Int J Biol Sci"},{"key":"2278_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00986-7","author":"E Zhu","year":"2025","unstructured":"Zhu E, et al. Progress and challenges of artificial intelligence in lung cancer clinical translation. NPJ Precis Oncol. 2025; 9(1):210. https:\/\/doi.org\/10.1038\/s41698-025-00986-7","journal-title":"NPJ Precis Oncol"},{"key":"2278_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1063716","author":"P Ku\u015bnierczyk","year":"2023","unstructured":"Ku\u015bnierczyk P. Genetic differences between smokers and never-smokers with lung cancer. Front Immunol. 2023; 14:1063716. https:\/\/doi.org\/10.3389\/fimmu.2023.1063716","journal-title":"Front Immunol"},{"key":"2278_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52129-4","author":"BR Gorman","year":"2024","unstructured":"Gorman BR, et al. Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun. 2024;15(1):8629. https:\/\/doi.org\/10.1038\/s41467-024-52129-4","journal-title":"Nat Commun"},{"key":"2278_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003191","author":"G Zaleskis","year":"2021","unstructured":"Zaleskis G, et al. Do the benefits of being a smoker hint at the existence of PD-1\/PD-L1 sensitizers for patients on single-agent immunotherapy? J Immunother Cancer. 2021; 9(8):e003191. https:\/\/doi.org\/10.1136\/jitc-2021-003191","journal-title":"J Immunother Cancer"},{"key":"2278_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00934-z","author":"P Zhu","year":"2022","unstructured":"Zhu P, et al. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3\/Jab1-PD-L1 signalling. Cell Commun Signal. 2022; 20(1):121. https:\/\/doi.org\/10.1186\/s12964-022-00934-z","journal-title":"Cell Commun Signal"},{"key":"2278_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100990","author":"L Dai","year":"2021","unstructured":"Dai L, et al. The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: a systematic review and meta-analysis. eClinicalMedicine. 2021; 38:100990. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100990","journal-title":"eClinicalMedicine"},{"key":"2278_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006939","author":"X Yin","year":"2023","unstructured":"Yin X, et al. Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy. J Immunother Cancer. 2023; 11(6):e006939. https:\/\/doi.org\/10.1136\/jitc-2023-006939","journal-title":"J Immunother Cancer"},{"key":"2278_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1238454","author":"P Liao","year":"2023","unstructured":"Liao P, et al. How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy. Front Immunol. 2023; 14:1238454. https:\/\/doi.org\/10.3389\/fimmu.2023.1238454","journal-title":"Front Immunol"},{"key":"2278_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404812","author":"J Kong","year":"2024","unstructured":"Kong J, et al. Assessing the predictive value of smoking history for immunotherapy outcomes in bladder cancer patients. Front Immunol. 2024; 15:1404812. https:\/\/doi.org\/10.3389\/fimmu.2024.1404812","journal-title":"Front Immunol"},{"key":"2278_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02580-1","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review. BMC Med. 2022; 20(1):426. https:\/\/doi.org\/10.1186\/s12916-022-02580-1","journal-title":"BMC Med"},{"issue":"3","key":"2278_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ijc.34929","volume":"155","author":"ML Rahman","year":"2024","unstructured":"Rahman ML, et al. A nested case-control study of untargeted plasma metabolomics and lung cancer among never\u2010smoking women within the prospective Shanghai Women\u2019s Health Study. Int J Cancer. 2024;155(3):508\u201318.","journal-title":"Int J Cancer"},{"key":"2278_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1629170","author":"R Jiao","year":"2025","unstructured":"Jiao R, et al. Immunotherapy enhances the risk of tumor oxidative stress and metastasis in lung cancer with radiation pneumonitis. Front Immunol. 2025; 16:1629170. https:\/\/doi.org\/10.3389\/fimmu.2025.1629170","journal-title":"Front Immunol"},{"key":"2278_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab089","author":"J Xie","year":"2021","unstructured":"Xie J, et al. Relationships between sleep traits and lung cancer risk: a prospective cohort study in UK Biobank. Sleep. 2021; 44(9):zsab089. https:\/\/doi.org\/10.1093\/sleep\/zsab089","journal-title":"Sleep"},{"key":"2278_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151246","author":"G Lanza","year":"2024","unstructured":"Lanza G, et al. The triad of sleep, immunity, and cancer: a mediating perspective. Cells. 2024; 13(15):1246. https:\/\/doi.org\/10.3390\/cells13151246","journal-title":"Cells"},{"key":"2278_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1374236","author":"F Yuan","year":"2024","unstructured":"Yuan F, et al. A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options. Front Immunol. 2024; 15:1374236. https:\/\/doi.org\/10.3389\/fimmu.2024.1374236","journal-title":"Front Immunol"},{"key":"2278_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101269","author":"K Proesmans","year":"2025","unstructured":"Proesmans K, Luik AI, Lahousse L. Sex-specific associations between sleep apnoea and lung cancer risk in patients with COPD: a nationwide prospective cohort study. Lancet Reg Health Eur. 2025. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101269.","journal-title":"Lancet Reg Health Eur"},{"key":"2278_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189252","author":"S Liao","year":"2025","unstructured":"Liao S, et al. Nervous system contributions to small cell lung cancer: lessons from diverse oncological studies. Biochim Biophys Acta Rev Cancer. 2025; 1880(1):189252. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189252","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"2278_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2023.2279813","author":"Z Cui","year":"2023","unstructured":"Cui Z, et al. Obstructive sleep apnea promotes the progression of lung cancer by modulating cancer cell invasion and cancer-associated fibroblast activation via TGF\u03b2 signaling. Redox Rep. 2023; 28(1):2279813. https:\/\/doi.org\/10.1080\/13510002.2023.2279813","journal-title":"Redox Rep"},{"key":"2278_CR56","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796022000592","author":"EL Zeilinger","year":"2022","unstructured":"Zeilinger EL, et al. Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study. Epidemiol Psychiatr Sci. 2022;31:e74. https:\/\/doi.org\/10.1017\/S2045796022000592","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"10","key":"2278_CR57","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1017\/S0033291724000850","volume":"54","author":"K-Y Pan","year":"2024","unstructured":"Pan K-Y, et al. The mediating role of health behaviors in the association between depression, anxiety and cancer incidence: an individual participant data meta-analysis. Psychol Med. 2024;54(10):2744\u201357.","journal-title":"Psychol Med"},{"issue":"20","key":"2278_CR58","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/cncr.34853","volume":"129","author":"LA van Tuijl","year":"2023","unstructured":"van Tuijl LA, et al. Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis. Cancer. 2023;129(20):3287\u201399.","journal-title":"Cancer"},{"issue":"13","key":"2278_CR59","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1017\/S0033291720004390","volume":"52","author":"C Trudel-Fitzgerald","year":"2020","unstructured":"Trudel-Fitzgerald C, et al. Depression, smoking, and lung cancer risk over 24 years among women. Psychol Med. 2020;52(13):2510\u20139.","journal-title":"Psychol Med"},{"key":"2278_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-01033-x","author":"Y Li","year":"2025","unstructured":"Li Y, et al. Colorectal cancer cells hijack a brain\u2013gut polysynaptic circuit from the lateral septum to enteric neurons to sustain tumor growth. Nat Cancer. 2025; 6(11):1800-1820. https:\/\/doi.org\/10.1038\/s43018-025-01033-x","journal-title":"Nat Cancer"},{"key":"2278_CR61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167725","author":"S-Y Xiong","year":"2023","unstructured":"Xiong S-Y, et al. A brain-tumor neural circuit controls breast cancer progression in mice. J Clin Invest. 2023; 133(24):e167725. https:\/\/doi.org\/10.1172\/JCI167725","journal-title":"J Clin Invest"},{"key":"2278_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01282-w","author":"Y Cao","year":"2024","unstructured":"Cao Y. Lack of basic rationale in epithelial-mesenchymal transition and its related concepts. Cell Biosci. 2024; 14(1):104. https:\/\/doi.org\/10.1186\/s13578-024-01282-w","journal-title":"Cell Biosci"},{"issue":"7965","key":"2278_CR63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618(7965):467\u201379.","journal-title":"Nature"},{"key":"2278_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02219-0","author":"Q Huang","year":"2025","unstructured":"Huang Q, et al. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer. 2025; 24(1):24. https:\/\/doi.org\/10.1186\/s12943-024-02219-0","journal-title":"Mol Cancer"},{"key":"2278_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cells12202471","author":"M Cohen","year":"2023","unstructured":"Cohen M, et al. Linkage between psychological factors and response to immune checkpoint inhibitor therapy: a preliminary study. Cells. 2023; 12(20):2471. https:\/\/doi.org\/10.3390\/cells12202471","journal-title":"Cells"},{"key":"2278_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104447","author":"J Li","year":"2023","unstructured":"Li J, et al. Effectiveness of mindfulness-based interventions on anxiety, depression, and fatigue in people with lung cancer: a systematic review and meta-analysis. Int J Nurs Stud. 2023; 140:104447. https:\/\/doi.org\/10.1016\/j.ijnurstu.2023.104447","journal-title":"Int J Nurs Stud"},{"key":"2278_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62459-6","author":"D Zhou","year":"2025","unstructured":"Zhou D, et al. Non-coding genetic elements of lung cancer identified using whole genome sequencing in 13,722 Chinese. Nat Commun. 2025; 16(1):7365. https:\/\/doi.org\/10.1038\/s41467-025-62459-6","journal-title":"Nat Commun"},{"key":"2278_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104566","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. Psychological outcomes of the systematic interventions based on the stress-induced situation, affective, bodily, and cognitive reactions framework for patients with lung cancer: a randomized clinical trial. Int J Nurs Stud. 2023; 146:104566. https:\/\/doi.org\/10.1016\/j.ijnurstu.2023.104566","journal-title":"Int J Nurs Stud"},{"key":"2278_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105489","author":"N Bunzeck","year":"2024","unstructured":"Bunzeck N, et al. Trajectories and contributing factors of neural compensation in healthy and pathological aging. Neurosci Biobehav Rev. 2024. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105489.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"2278_CR70","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.jtho.2021.07.025","volume":"16","author":"SL Quaife","year":"2021","unstructured":"Quaife SL, et al. Psychological Targets for Lung Cancer Screening Uptake: A Prospective Longitudinal Cohort Study. J Thorac Oncol. 2021;16(12):2016\u201328.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2278_CR71","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.chest.2021.02.050","volume":"160","author":"J Turner","year":"2021","unstructured":"Turner J, et al. Risk Perception Among a Lung Cancer Screening Population. Chest. 2021;160(2):718\u201330.","journal-title":"Chest"},{"key":"2278_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108750","author":"Z-K Dong","year":"2024","unstructured":"Dong Z-K, et al. Neurobiology of cancer: adrenergic signaling and drug repurposing. Pharmacol Ther. 2024. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108750.","journal-title":"Pharmacol Ther"},{"key":"2278_CR73","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011609","author":"E Repasky","year":"2025","unstructured":"Repasky E, Mohammadpour H. Targeting nerve growth factor: an Achilles\u2019 heel for tumors? J Immunother Cancer. 2025; 13(5):e011609. https:\/\/doi.org\/10.1136\/jitc-2025-011609","journal-title":"J Immunother Cancer"},{"key":"2278_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112321","author":"S Yin","year":"2025","unstructured":"Yin S, et al. Sleep deprivation-induced sympathetic activation promotes pro-tumoral macrophage phenotype via the ADRB2\/KLF4 pathway to facilitate NSCLC metastasis. iScience. 2025; 28(5):112321. https:\/\/doi.org\/10.1016\/j.isci.2025.112321","journal-title":"iScience"},{"key":"2278_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810652","author":"K Ieguchi","year":"2022","unstructured":"Ieguchi K, et al. The sympathetic nervous system contributes to the establishment of pre-metastatic pulmonary microenvironments. Int J Mol Sci. 2022; 23(18):10652. https:\/\/doi.org\/10.3390\/ijms231810652","journal-title":"Int J Mol Sci"},{"key":"2278_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062553","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Neuroimmune interactions and their role in immune cell trafficking in cardiovascular diseases and cancer. Int J Mol Sci. 2025; 26(6):2553. https:\/\/doi.org\/10.3390\/ijms26062553","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2278_CR77","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.immuni.2025.05.005","volume":"58","author":"W Li","year":"2025","unstructured":"Li W, et al. A brain-to-lung signal from GABAergic neurons to ADRB2\u2009+\u2009interstitial macrophages promotes pulmonary inflammatory responses. Immunity. 2025;58(8):2069-2085.e9. https:\/\/doi.org\/10.1016\/j.immuni.2025.05.005","journal-title":"Immunity"},{"key":"2278_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217817","author":"X Chen","year":"2025","unstructured":"Chen X, et al. Neurodegeneration of local sympathetic inputs promotes colorectal cancer progression. Cancer Lett. 2025; 625:217817. https:\/\/doi.org\/10.1016\/j.canlet.2025.217817","journal-title":"Cancer Lett"},{"key":"2278_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122603","author":"S Zuo","year":"2024","unstructured":"Zuo S, et al. Regulating tumor innervation by nanodrugs potentiates cancer immunochemotherapy and relieve chemotherapy-induced neuropathic pain. Biomaterials. 2024; 309:122603. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122603","journal-title":"Biomaterials"},{"key":"2278_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101875","author":"D Benzaquen","year":"2024","unstructured":"Benzaquen D, et al. The crosstalk between nerves and cancer\u2014a poorly understood phenomenon and new possibilities. Cancers (Basel). 2024;16(10):1875. https:\/\/doi.org\/10.3390\/cancers16101875","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2278_CR81","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/glia.24586","volume":"72","author":"MM Rangel-Sosa","year":"2024","unstructured":"Rangel-Sosa MM, Mann F, Chauvet S. Pancreatic Schwann cell reprogramming supports cancer\u2010associated neuronal remodeling. Glia. 2024;72(10):1840\u201361.","journal-title":"Glia"},{"issue":"4","key":"2278_CR82","doi-asserted-by":"publisher","first-page":"LMT63","DOI":"10.2217\/lmt-2023-0006","volume":"12","author":"FT Garramona","year":"2024","unstructured":"Garramona FT, Cunha TF, Vieira JS, et al. Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies. Lung Cancer Manag. 2024;12(4):LMT63.","journal-title":"Lung Cancer Manag"},{"key":"2278_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188884","author":"Y-T Li","year":"2023","unstructured":"Li Y-T, Yuan W-Z, Jin W-L. Vagus innervation in the gastrointestinal tumor: current understanding and challenges. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188884. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188884","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"2278_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217539","author":"P Martinez","year":"2025","unstructured":"Martinez P, Sabatier J-M. Malignant tumors in vagal-innervated organs: exploring its homeostatic role. Cancer Lett. 2025;617:217539. https:\/\/doi.org\/10.1016\/j.canlet.2025.217539","journal-title":"Cancer Lett"},{"key":"2278_CR85","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2024.04.027","volume":"120","author":"A Falvey","year":"2024","unstructured":"Falvey A, et al. Electrical stimulation of the dorsal motor nucleus of the vagus in male mice can regulate inflammation without affecting the heart rate. Brain Behav Immun. 2024;120:630\u20139.","journal-title":"Brain Behav Immun"},{"key":"2278_CR86","doi-asserted-by":"crossref","unstructured":"Kressel AM et al. Identification of a brainstem locus that inhibits tumor necrosis factor. Proceedings of the National Academy of Sciences, 2020. 117(47): pp. 29803\u201329810.","DOI":"10.1073\/pnas.2008213117"},{"issue":"8087","key":"2278_CR87","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41586-025-09492-z","volume":"646","author":"S Savchuk","year":"2025","unstructured":"Savchuk S, et al. Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis. Nature. 2025;646(8087):1232\u201342.","journal-title":"Nature"},{"key":"2278_CR88","doi-asserted-by":"publisher","unstructured":"Yan Z et al. Vagus Nerve Preservation for Early Distal Gastric Cancer With Monitoring and Indocyanine Green Labeling. JAMA Surg, 2025; 160(1):85-92. 160(1). https:\/\/doi.org\/10.1001\/jamasurg.2024.5077","DOI":"10.1001\/jamasurg.2024.5077"},{"issue":"6","key":"2278_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.202006-2359OC","volume":"203","author":"JA Smith","year":"2021","unstructured":"Smith JA, et al. Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights. Am J Respir Crit Care Med. 2021;203(6):737\u201345.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7\u20138","key":"2278_CR90","doi-asserted-by":"publisher","first-page":"95","DOI":"10.18632\/oncoscience.357","volume":"4","author":"SL Rains","year":"2017","unstructured":"Rains SL, Amaya CN, Bryan BA. Beta-adrenergic receptors are expressed across diverse cancers. Oncoscience. 2017;4(7\u20138):95\u2013105.","journal-title":"Oncoscience"},{"issue":"1","key":"2278_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11481-019-09891-w","volume":"15","author":"MB Nilsson","year":"2019","unstructured":"Nilsson MB, Le X. Heymach, \u03b2-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers. J Neuroimmune Pharmacol. 2019;15(1):27\u201336.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"2278_CR92","first-page":"2227","volume":"8","author":"Q Huang","year":"2018","unstructured":"Huang Q, Tan Q, Mao K, et al. The role of adrenergic receptors in lung cancer. Am J Cancer Res. 2018;8(11):2227\u201337.","journal-title":"Am J Cancer Res"},{"key":"2278_CR93","doi-asserted-by":"publisher","unstructured":"Sun J et al. Role of \u03b2-adrenergic signaling and the NLRP3 inflammasome in chronic intermittent hypoxia-induced murine lung cancer progression. Respir Res, 2024;25(1):347. https:\/\/doi.org\/10.1186\/s12931-024-02969-x","DOI":"10.1186\/s12931-024-02969-x"},{"key":"2278_CR94","doi-asserted-by":"publisher","unstructured":"Jeong J-H et al. \u03b22-Adrenergic Receptor Signaling Pathway Stimulates the Migration and Invasion of Cancer Cells via Src Activation. Molecules, 2022;27(18):5940. https:\/\/doi.org\/10.3390\/molecules27185940","DOI":"10.3390\/molecules27185940"},{"issue":"22","key":"2278_CR95","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1158\/0008-5472.CAN-16-0990","volume":"76","author":"HJ Jang","year":"2016","unstructured":"Jang HJ, Boo HJ, Lee HJ, Min HY, Lee HY. Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells. Cancer Res. 2016;76(22):6607\u201319.","journal-title":"Cancer Res"},{"issue":"3","key":"2278_CR96","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2024.01.013","volume":"42","author":"X-Y He","year":"2024","unstructured":"He X-Y, et al. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment. Cancer Cell. 2024;42(3):474\u2013e48612.","journal-title":"Cancer Cell"},{"key":"2278_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050575","author":"KR Chaudhary","year":"2019","unstructured":"Chaudhary KR, et al. Effects of \u03b2-adrenergic antagonists on chemoradiation therapy for locally advanced non-small cell lung cancer. J Clin Med. 2019;8(5):575. https:\/\/doi.org\/10.3390\/jcm8050575","journal-title":"J Clin Med"},{"issue":"2","key":"2278_CR98","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ijc.33552","volume":"149","author":"M Cao","year":"2021","unstructured":"Cao M, et al. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through \u03b2\u2010adrenergic\u2010activated CXCL5\u2010CXCR2\u2010Erk signaling cascades. Int J Cancer. 2021;149(2):460\u201372.","journal-title":"Int J Cancer"},{"key":"2278_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01747-y","author":"J Lu","year":"2024","unstructured":"Lu J, et al. Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress. Cell Commun Signal. 2024;22(1):375. https:\/\/doi.org\/10.1186\/s12964-024-01747-y","journal-title":"Cell Commun Signal"},{"issue":"7364","key":"2278_CR100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature10368","volume":"477","author":"MR Hara","year":"2011","unstructured":"Hara MR, et al. A stress response pathway regulates DNA damage through \u03b22-adrenoreceptors and \u03b2-arrestin-1. Nature. 2011;477(7364):349\u201353.","journal-title":"Nature"},{"issue":"11","key":"2278_CR101","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/onc.2016.319","volume":"36","author":"M Hulsurkar","year":"2016","unstructured":"Hulsurkar M, et al. Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. Oncogene. 2016;36(11):1525\u201336.","journal-title":"Oncogene"},{"issue":"4","key":"2278_CR102","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10735-022-10076-8","volume":"53","author":"C Gong","year":"2022","unstructured":"Gong C, et al. \u03b22-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. J Mol Histol. 2022;53(4):645\u201355.","journal-title":"J Mol Histol"},{"key":"2278_CR103","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2022.01.017","volume":"531","author":"M Chaib","year":"2022","unstructured":"Chaib M, et al. PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8\u2009+\u2009T cells in breast cancer. Cancer Lett. 2022;531:98\u2013108.","journal-title":"Cancer Lett"},{"key":"2278_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04603-4","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, et al. ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells. Cell Death Dis. 2022;13(2):141. https:\/\/doi.org\/10.1038\/s41419-022-04603-4","journal-title":"Cell Death Dis"},{"issue":"11","key":"2278_CR105","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00262-020-02627-3","volume":"69","author":"M Zheng","year":"2020","unstructured":"Zheng M, et al. ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma. Cancer Immunol Immunother. 2020;69(11):2345\u201355.","journal-title":"Cancer Immunol Immunother"},{"key":"2278_CR106","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb5817","author":"M Perego","year":"2020","unstructured":"Perego M, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Sci Transl Med. 2020;12(572):eabb5817. https:\/\/doi.org\/10.1126\/scitranslmed.abb5817","journal-title":"Sci Transl Med"},{"issue":"6","key":"2278_CR107","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-024-02929-4","volume":"30","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, et al. Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer. Nat Med. 2024;30(6):1680\u20138.","journal-title":"Nat Med"},{"key":"2278_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007528","author":"K Wu","year":"2023","unstructured":"Wu K, et al. Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma. J Immunother Cancer. 2023;11(10):e007528. https:\/\/doi.org\/10.1136\/jitc-2023-007528","journal-title":"J Immunother Cancer"},{"key":"2278_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171065","author":"R Herranz","year":"2023","unstructured":"Herranz R, et al. Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro. Front Immunol. 2023;14:1171065. https:\/\/doi.org\/10.3389\/fimmu.2023.1171065","journal-title":"Front Immunol"},{"key":"2278_CR110","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227. https:\/\/doi.org\/10.1126\/science.aao4227","journal-title":"Science"},{"key":"2278_CR111","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0328","author":"AP Reddy","year":"2025","unstructured":"Reddy AP, et al. Role of Serotonylation and SERT posttranslational modifications in Alzheimer\u2019s disease pathogenesis. Aging Dis. 2025;16(2):841-858. https:\/\/doi.org\/10.14336\/AD.2024.0328","journal-title":"Aging Dis"},{"key":"2278_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116743","author":"SG Chavan","year":"2025","unstructured":"Chavan SG, et al. Recent advances of electrochemical and optical point-of-care biosensors for detecting neurotransmitter serotonin biomarkers. Biosens Bioelectron. 2025;267:116743. https:\/\/doi.org\/10.1016\/j.bios.2024.116743","journal-title":"Biosens Bioelectron"},{"key":"2278_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107154","author":"K Hurtado","year":"2024","unstructured":"Hurtado K, et al. Serotonin regulation of mitochondria in kidney diseases. Pharmacol Res. 2024;203:107154. https:\/\/doi.org\/10.1016\/j.phrs.2024.107154","journal-title":"Pharmacol Res"},{"key":"2278_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01195-0","author":"VK Sharma","year":"2023","unstructured":"Sharma VK, Loh YP. The discovery, structure, and function of 5-HTR1E serotonin receptor. Cell Commun Signal. 2023;21(1):235. https:\/\/doi.org\/10.1186\/s12964-023-01195-0","journal-title":"Cell Commun Signal"},{"key":"2278_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1750","author":"L Chen","year":"2024","unstructured":"Chen L, et al. Serotonin signalling in cancer: emerging mechanisms and therapeutic opportunities. Clin Transl Med. 2024;14(7):e1750. https:\/\/doi.org\/10.1002\/ctm2.1750","journal-title":"Clin Transl Med"},{"key":"2278_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03202-9","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, et al. Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer. J Exp Clin Cancer Res. 2024;43(1):284. https:\/\/doi.org\/10.1186\/s13046-024-03202-9","journal-title":"J Exp Clin Cancer Res"},{"key":"2278_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8188","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.abc8188.","journal-title":"Sci Transl Med"},{"issue":"14","key":"2278_CR118","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1016\/j.cell.2025.06.012","volume":"188","author":"MD Gershon","year":"2025","unstructured":"Gershon MD. Targeting serotonin transporter boosts tumor-fighting T cells. Cell. 2025;188(14):3631\u20132.","journal-title":"Cell"},{"issue":"4","key":"2278_CR119","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41423-023-00982-6","volume":"20","author":"Z Wang","year":"2023","unstructured":"Wang Z, et al. HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation. Cell Mol Immunol. 2023;20(4):404\u201318.","journal-title":"Cell Mol Immunol"},{"key":"2278_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04124-6","author":"M Xie","year":"2021","unstructured":"Xie M, Fu X-g, Jiang K. Notch1\/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer. Cell Death Dis. 2021;12(9):832. https:\/\/doi.org\/10.1038\/s41419-021-04124-6","journal-title":"Cell Death Dis"},{"key":"2278_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217150","author":"T Ling","year":"2024","unstructured":"Ling T, et al. Serotonylation in tumor-associated fibroblasts contributes to the tumor-promoting roles of serotonin in colorectal cancer. Cancer Lett. 2024;600:217150. https:\/\/doi.org\/10.1016\/j.canlet.2024.217150","journal-title":"Cancer Lett"},{"issue":"14","key":"2278_CR122","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1016\/j.cell.2025.04.032","volume":"188","author":"B Li","year":"2025","unstructured":"Li B, et al. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025;188(14):3823\u2013e384221.","journal-title":"Cell"},{"key":"2278_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116014","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. The role of tumor-associated macrophages in lung cancer: from mechanism to small molecule therapy. Biomed Pharmacother. 2024. https:\/\/doi.org\/10.1016\/j.biopha.2023.116014.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2278_CR124","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.7150\/thno.55986","volume":"11","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics. 2021;11(11):5296\u2013312.","journal-title":"Theranostics"},{"issue":"1","key":"2278_CR125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","volume":"75","author":"B Channer","year":"2023","unstructured":"Channer B, et al. Dopamine, Immunity, and Disease. Pharmacol Rev. 2023;75(1):62\u2013158.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"2278_CR126","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.chembiol.2021.04.005","volume":"28","author":"MR Post","year":"2021","unstructured":"Post MR, Sulzer D. The chemical tools for imaging dopamine release. Cell Chem Biology. 2021;28(6):748\u201364.","journal-title":"Cell Chem Biology"},{"issue":"4","key":"2278_CR127","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/cells10040735","volume":"10","author":"L Speranza","year":"2021","unstructured":"Speranza L, di Porzio U, Viggiano D, de Donato A, Volpicelli F, Dopamine. The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control. Cells. 2021;10(4):735.","journal-title":"Cells"},{"issue":"10423","key":"2278_CR128","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie T, et al. Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet. 2024;403(10423):305\u201324.","journal-title":"Lancet"},{"issue":"5","key":"2278_CR129","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1021\/acsnano.1c00453","volume":"15","author":"J Garc\u00eda-Pardo","year":"2021","unstructured":"Garc\u00eda-Pardo J, et al. Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson\u2019s Disease. ACS Nano. 2021;15(5):8592\u2013609.","journal-title":"ACS Nano"},{"key":"2278_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07693-y","author":"SK Alam","year":"2025","unstructured":"Alam SK, et al. Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression. Cell Death Dis. 2025;16(1):370. https:\/\/doi.org\/10.1038\/s41419-025-07693-y","journal-title":"Cell Death Dis"},{"key":"2278_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-021-00144-2","author":"Y Fan","year":"2021","unstructured":"Fan Y, et al. Mechanical tibial loading remotely suppresses brain tumors by dopamine-mediated downregulation of CCN4. Bone Res. 2021;9(1):26. https:\/\/doi.org\/10.1038\/s41413-021-00144-2","journal-title":"Bone Res"},{"issue":"2","key":"2278_CR132","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.immuni.2022.12.017","volume":"56","author":"Y Cao","year":"2023","unstructured":"Cao Y, et al. Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity. Immunity. 2023;56(2):320\u2013e3359.","journal-title":"Immunity"},{"key":"2278_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115364","author":"Y Wu","year":"2025","unstructured":"Wu Y, et al. DA-DRD5 signaling reprograms B cells to promote CD8 + T cell-mediated antitumor immunity. Cell Rep. 2025;44(3):115364. https:\/\/doi.org\/10.1016\/j.celrep.2025.115364","journal-title":"Cell Rep"},{"issue":"8","key":"2278_CR134","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.cmet.2024.07.008","volume":"36","author":"C Mo","year":"2024","unstructured":"Mo C, et al. Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosis. Cell Metabol. 2024;36(8):1839\u2013e185712.","journal-title":"Cell Metabol"},{"issue":"12","key":"2278_CR135","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cac2.12103","volume":"40","author":"Y Yan","year":"2020","unstructured":"Yan Y, et al. Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma. Cancer Commun. 2020;40(12):694\u2013710.","journal-title":"Cancer Commun"},{"key":"2278_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100894","author":"H-M Jeon","year":"2023","unstructured":"Jeon H-M, et al. Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4\/5. Neoplasia. 2023;39:100894. https:\/\/doi.org\/10.1016\/j.neo.2023.100894","journal-title":"Neoplasia"},{"issue":"8","key":"2278_CR137","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/neuonc\/noaf098","volume":"27","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Z, Li R, et al. S-palmitoylation of c-MET by CK2\u03b1-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity. Neuro Oncol. 2025;27(8):1972\u201386.","journal-title":"Neuro Oncol"},{"issue":"17","key":"2278_CR138","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1158\/0008-5472.CAN-21-4084","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yan SM, Pu Z, et al. Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8\u2009+\u2009T Cells and Antitumor Immunity. Cancer Res. 2022;82(17):3130\u201342.","journal-title":"Cancer Res"},{"issue":"3","key":"2278_CR139","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.CAN-20-0617","volume":"81","author":"W Guo","year":"2021","unstructured":"Guo W, et al. Dysregulated Glutamate Transporter SLC1A1 Propels Cystine Uptake via Xc\u2009\u2013\u2009for Glutathione Synthesis in Lung Cancer. Cancer Res. 2021;81(3):552\u201366.","journal-title":"Cancer Res"},{"key":"2278_CR140","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0108","author":"R Rosell","year":"2023","unstructured":"Rosell R, et al. Biological insights in non-small cell lung cancer. Cancer Biol Med. 2023;20(7):500-518. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2023.0108","journal-title":"Cancer Biol Med"},{"issue":"21","key":"2278_CR141","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1016\/j.neuron.2025.10.007","volume":"113","author":"X Huang","year":"2025","unstructured":"Huang X, Taylor MD. Glutamate promotes glioma growth via a non-excitable, receptor tyrosine kinase-mediated mechanism. Neuron. 2025;113(21):3493\u20135.","journal-title":"Neuron"},{"key":"2278_CR142","doi-asserted-by":"publisher","unstructured":"Wen D et al. NF-\u03baB-mediated EAAT3 upregulation in antioxidant defense and ferroptosis sensitivity in lung cancer. Cell Death Dis, 2025;16(1):124. https:\/\/doi.org\/10.1038\/s41419-025-07453-y","DOI":"10.1038\/s41419-025-07453-y"},{"issue":"21","key":"2278_CR143","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.neuron.2025.08.005","volume":"113","author":"C Anastasaki","year":"2025","unstructured":"Anastasaki C, et al. Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth. Neuron. 2025;113(21):3582-3600.e7.","journal-title":"Neuron"},{"issue":"5","key":"2278_CR144","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.devcel.2024.01.010","volume":"59","author":"K Ishibashi","year":"2024","unstructured":"Ishibashi K, et al. Astrocyte-induced mGluR1 activates human lung cancer brain metastasis via glutamate-dependent stabilization of EGFR. Dev Cell. 2024;59(5):579\u2013e5946.","journal-title":"Dev Cell"},{"key":"2278_CR145","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2497172","author":"J Chen","year":"2025","unstructured":"Chen J, et al. Glutamate promotes CCL2 expression to recruit tumor-associated macrophages by restraining EZH2-mediated histone methylation in hepatocellular carcinoma. Oncoimmunology. 2025;14(1):2497172. https:\/\/doi.org\/10.1080\/2162402X.2025.2497172","journal-title":"Oncoimmunology"},{"key":"2278_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172657","author":"M Tabatabaee","year":"2022","unstructured":"Tabatabaee M, Menard F. Glutamate signaling and filopodiagenesis of astrocytoma cells in brain cancers: survey and questions. Cells. 2022;11(17):2657. https:\/\/doi.org\/10.3390\/cells11172657","journal-title":"Cells"},{"key":"2278_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48757-5","author":"J Meyer","year":"2024","unstructured":"Meyer J, et al. Glioblastoma disrupts cortical network activity at multiple spatial and temporal scales. Nat Commun. 2024;15(1):4503. https:\/\/doi.org\/10.1038\/s41467-024-48757-5","journal-title":"Nat Commun"},{"key":"2278_CR148","doi-asserted-by":"publisher","unstructured":"Ren L et al. Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. Cancer Cell, 2025;43(12):2241-2258.e8. https:\/\/doi.org\/10.1016\/j.ccell.2025.09.003","DOI":"10.1016\/j.ccell.2025.09.003"},{"issue":"7986","key":"2278_CR149","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature. 2023;623(7986):366\u201374.","journal-title":"Nature"},{"key":"2278_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007955","author":"J Tian","year":"2022","unstructured":"Tian J, et al. A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice. Front Immunol. 2022;13:1007955. https:\/\/doi.org\/10.3389\/fimmu.2022.1007955","journal-title":"Front Immunol"},{"key":"2278_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2024.141750","author":"T Tufail","year":"2025","unstructured":"Tufail T, et al. GABA (\u03b3-aminobutyric acid) enrichment and detection methods in cereals: unlocking sustainable health benefits. Food Chem. 2025;464(Pt 3):141750. https:\/\/doi.org\/10.1016\/j.foodchem.2024.141750","journal-title":"Food Chem"},{"issue":"13","key":"2278_CR152","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1007\/s00018-021-03846-2","volume":"78","author":"E Sallard","year":"2021","unstructured":"Sallard E, Letourneur D, Legendre P. Electrophysiology of ionotropic GABA receptors. Cell Mol Life Sci. 2021;78(13):5341\u201370.","journal-title":"Cell Mol Life Sci"},{"key":"2278_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115800","author":"X Qian","year":"2023","unstructured":"Qian X, et al. Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.115800.","journal-title":"Biomed Pharmacother"},{"key":"2278_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03315-9","author":"M Xie","year":"2025","unstructured":"Xie M, et al. GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer. J Exp Clin Cancer Res. 2025;44(1):61. https:\/\/doi.org\/10.1186\/s13046-025-03315-9","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2278_CR155","first-page":"1476","volume":"27","author":"D Das","year":"2025","unstructured":"Das D, et al. Tumor cells upregulate neurotransmitter GABA in the choroid plexus through STAT6-Bestrophin1 signaling, promoting leptomeningeal dissemination. Neurooncology. 2025;27(6):1476\u201390.","journal-title":"Neurooncology"},{"issue":"2","key":"2278_CR156","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24(2):230\u201341.","journal-title":"Nat Cell Biol"},{"key":"2278_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02921-9","author":"H Bao","year":"2023","unstructured":"Bao H, et al. GABA induced by sleep deprivation promotes the proliferation and migration of colon tumors through miR-223-3p endogenous pathway and exosome pathway. J Exp Clin Cancer Res. 2023;42(1):344. https:\/\/doi.org\/10.1186\/s13046-023-02921-9","journal-title":"J Exp Clin Cancer Res"},{"key":"2278_CR158","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060426","author":"MM Naffaa","year":"2025","unstructured":"Naffaa MM, Yin HH. Lateral ventricular neural stem cells provide negative feedback to circuit activation through GABAergic signaling. Cells. 2025;14(6):426. https:\/\/doi.org\/10.3390\/cells14060426","journal-title":"Cells"},{"key":"2278_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114350","author":"Y Shan","year":"2023","unstructured":"Shan Y, et al. Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis. Front Immunol. 2023;14:1114350. https:\/\/doi.org\/10.3389\/fimmu.2023.1114350","journal-title":"Front Immunol"},{"key":"2278_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114410","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. GABAergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.114410.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2278_CR161","first-page":"914","volume":"24","author":"K Deshpande","year":"2022","unstructured":"Deshpande K, et al. Neuronal exposure induces neurotransmitter signaling and synaptic mediators in tumors early in brain metastasis. Neurooncology. 2022;24(6):914\u201324.","journal-title":"Neurooncology"},{"key":"2278_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42260-z","author":"D Im","year":"2023","unstructured":"Im D, et al. Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor. Nat Commun. 2023;14(1):6538. https:\/\/doi.org\/10.1038\/s41467-023-42260-z","journal-title":"Nat Commun"},{"issue":"4","key":"2278_CR163","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jaci.2024.12.1081","volume":"155","author":"S Heidarzadeh-Asl","year":"2025","unstructured":"Heidarzadeh-Asl S, et al. Novel insights on the biology and immunologic effects of histamine: A road map for allergists and mast cell biologists. J Allergy Clin Immunol. 2025;155(4):1095\u2013114.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2278_CR164","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41401-020-00548-6","volume":"42","author":"Y-y Zhao","year":"2020","unstructured":"Zhao Y-y, et al. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K\/Akt\/mTOR and MEK\/ERK signaling pathways and blocking EMT. Acta Pharmacol Sin. 2020;42(8):1288\u201397.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2278_CR165","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","volume":"40","author":"H Li","year":"2022","unstructured":"Li H, et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1. Cancer Cell. 2022;40(1):36\u2013e529.","journal-title":"Cancer Cell"},{"issue":"1","key":"2278_CR166","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccell.2021.11.007","volume":"40","author":"S Chen","year":"2022","unstructured":"Chen S, Luster AD. Antihistamines for cancer immunotherapy: More than just treating allergies. Cancer Cell. 2022;40(1):9\u201311.","journal-title":"Cancer Cell"},{"issue":"9","key":"2278_CR167","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/glia.24039","volume":"69","author":"P Xia","year":"2021","unstructured":"Xia P, et al. Histamine triggers microglial responses indirectly via astrocytes and purinergic signaling. Glia. 2021;69(9):2291\u2013304.","journal-title":"Glia"},{"key":"2278_CR168","unstructured":"Pericytes. in the Development and Progression of Brain Diseases. aging and disease, 2025."},{"issue":"4","key":"2278_CR169","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ijc.34028","volume":"151","author":"M Matsushita","year":"2022","unstructured":"Matsushita M, et al. High-fat diet promotes prostate cancer growth through histamine signaling. Int J Cancer. 2022;151(4):623\u201336.","journal-title":"Int J Cancer"},{"key":"2278_CR170","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2247181","author":"H Kim","year":"2023","unstructured":"Kim H, Hong JH. Trafficking of carbonic anhydrase 12 and bicarbonate transporters by histamine stimulation mediates intracellular acidic scenario in lung cancer cells. J Enzyme Inhib Med Chem. 2023;38(1):2247181. https:\/\/doi.org\/10.1080\/14756366.2023.2247181","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"2278_CR171","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell. 2022;29(11):1531\u201346. .e7.","journal-title":"Cell Stem Cell"},{"key":"2278_CR172","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5495","author":"M-H Chien","year":"2025","unstructured":"Chien M-H, et al. The off\u2011target effect of loratadine triggers autophagy\u2011mediated apoptosis in lung adenocarcinoma cells by deactivating JNK, p38, and STAT3 signaling through both PP2A\u2011dependent and independent pathways. Int J Mol Med. 2025;55(4):54. https:\/\/doi.org\/10.3892\/ijmm.2025.5495","journal-title":"Int J Mol Med"},{"key":"2278_CR173","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-024-10237-z","author":"D Sigorski","year":"2025","unstructured":"Sigorski D, et al. Neuropeptide Y in cancer\u2014biological functions and potential clinical implications. Cancer Metastasis Rev. 2025;44(1):21. https:\/\/doi.org\/10.1007\/s10555-024-10237-z","journal-title":"Cancer Metastasis Rev"},{"key":"2278_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60730-4","author":"A Tyagi","year":"2025","unstructured":"Tyagi A, et al. Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI. Nat Commun. 2025;16(1):5608. https:\/\/doi.org\/10.1038\/s41467-025-60730-4","journal-title":"Nat Commun"},{"key":"2278_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118117","author":"K Tomi\u0107","year":"2025","unstructured":"Tomi\u0107 K, et al. Neuropeptide Y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy. Biomed Pharmacother. 2025. https:\/\/doi.org\/10.1016\/j.biopha.2025.118117.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2278_CR176","doi-asserted-by":"publisher","first-page":"eadq4416","DOI":"10.1126\/sciadv.adq4416","volume":"11","author":"CR Chambers","year":"2025","unstructured":"Chambers CR, Watakul S, Schofield P, et al. Targeting the NPY\/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis. Sci Adv. 2025;11(11):eadq4416.","journal-title":"Sci Adv"},{"key":"2278_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00657-7","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review. Cell Biosci. 2021;11(1):151. https:\/\/doi.org\/10.1186\/s13578-021-00657-7","journal-title":"Cell Biosci"},{"issue":"9","key":"2278_CR178","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/ijc.34193","volume":"151","author":"LH Yang","year":"2022","unstructured":"Yang LH, et al. Neuronal survival factor VGF promotes chemoresistance and predicts poor prognosis in lung cancers with neuroendocrine feature. Int J Cancer. 2022;151(9):1611\u201325.","journal-title":"Int J Cancer"},{"key":"2278_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05408-7","author":"J Li","year":"2023","unstructured":"Li J, et al. Mendelian randomization analyses explore the relationship between cathepsins and lung cancer. Commun Biol. 2023;6(1):1019. https:\/\/doi.org\/10.1038\/s42003-023-05408-7","journal-title":"Commun Biol"},{"issue":"5","key":"2278_CR180","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.apsb.2025.03.025","volume":"15","author":"Z Dong","year":"2025","unstructured":"Dong Z, Wang Y, Jin W. The neuroscience of cancer: Focus on neuropeptidergic systems. Acta Pharm Sinica B. 2025;15(5):2323\u201350.","journal-title":"Acta Pharm Sinica B"},{"issue":"17","key":"2278_CR181","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.neuron.2025.07.017","volume":"113","author":"D Sur","year":"2025","unstructured":"Sur D, et al. Entangled cellular and molecular relationships at the sensory neuron-cancer interface. Neuron. 2025;113(17):2760\u201390.","journal-title":"Neuron"},{"issue":"2","key":"2278_CR182","doi-asserted-by":"publisher","first-page":"e0345821","DOI":"10.1128\/mbio.03458-21","volume":"13","author":"MA Matilla","year":"2022","unstructured":"Matilla MA, Velando F, Tajuelo A, et al. Chemotaxis of the Human Pathogen Pseudomonas aeruginosa to the Neurotransmitter Acetylcholine. mBio. 2022;13(2):e0345821.","journal-title":"mBio"},{"key":"2278_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030237","author":"A Crestini","year":"2024","unstructured":"Crestini A, et al. A systematic review on drugs acting as nicotinic acetylcholine receptor agonists in the treatment of dementia. Cells. 2024;13(3):237. https:\/\/doi.org\/10.3390\/cells13030237","journal-title":"Cells"},{"key":"2278_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.131018","author":"AE Kassab","year":"2024","unstructured":"Kassab AE, Gedawy EM, Sayed AS. Fused thiophene as a privileged scaffold: a review on anti-Alzheimer\u2019s disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and A\u03b2 aggregation. Int J Biol Macromol. 2024;265(Pt 2):131018. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131018","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"2278_CR185","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1038\/s41380-022-01643-2","volume":"27","author":"Y Yamahashi","year":"2022","unstructured":"Yamahashi Y, et al. Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-\u03b2-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning. Mol Psychiatry. 2022;27(8):3479\u201392.","journal-title":"Mol Psychiatry"},{"key":"2278_CR186","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jtos.2024.01.006","volume":"32","author":"T Masuoka","year":"2024","unstructured":"Masuoka T, et al. Corneal acetylcholine regulates sensory nerve activity via nicotinic receptors. Ocul Surf. 2024;32:60\u201370.","journal-title":"Ocul Surf"},{"key":"2278_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545579","author":"Y-l Zheng","year":"2025","unstructured":"Zheng Y-l, et al. Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review. Front Immunol. 2025;16:1545579. https:\/\/doi.org\/10.3389\/fimmu.2025.1545579","journal-title":"Front Immunol"},{"issue":"1","key":"2278_CR188","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/acsptsci.3c00138","volume":"7","author":"K Arunrungvichian","year":"2023","unstructured":"Arunrungvichian K, et al. Targeting Alpha7 Nicotinic Acetylcholine Receptors in Lung Cancer: Insights, Challenges, and Therapeutic Strategies. ACS Pharmacol Translational Sci. 2023;7(1):28\u201341.","journal-title":"ACS Pharmacol Translational Sci"},{"key":"2278_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117105","author":"H Zou","year":"2024","unstructured":"Zou H, et al. Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation. Biomed Pharmacother. 2024. https:\/\/doi.org\/10.1016\/j.biopha.2024.117105.","journal-title":"Biomed Pharmacother"},{"key":"2278_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01761-z","author":"Y Fu","year":"2024","unstructured":"Fu Y, et al. Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis. Signal Transduct Target Ther. 2024;9(1):63. https:\/\/doi.org\/10.1038\/s41392-024-01761-z","journal-title":"Signal Transduct Target Ther"},{"key":"2278_CR191","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04742-7","author":"Y Jiao","year":"2023","unstructured":"Jiao Y, et al. Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via \u03b15-nAChR\/FHIT pathway. Cell Mol Life Sci. 2023;80(5):119. https:\/\/doi.org\/10.1007\/s00018-023-04742-7","journal-title":"Cell Mol Life Sci"},{"key":"2278_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576929","author":"W Chen","year":"2020","unstructured":"Chen W, Shu Q, Fan J. Neural regulation of interactions between group 2 innate lymphoid cells and pulmonary immune cells. Front Immunol. 2020;11:576929. https:\/\/doi.org\/10.3389\/fimmu.2020.576929","journal-title":"Front Immunol"},{"key":"2278_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02441-4","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. Mol Cancer. 2025;24(1):231. https:\/\/doi.org\/10.1186\/s12943-025-02441-4","journal-title":"Mol Cancer"},{"issue":"12","key":"2278_CR194","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/s41418-023-01234-w","volume":"30","author":"S Yuan","year":"2023","unstructured":"Yuan S, et al. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer. Cell Death Differ. 2023;30(12):2477\u201390.","journal-title":"Cell Death Differ"},{"key":"2278_CR195","doi-asserted-by":"publisher","first-page":"118637","DOI":"10.1016\/j.biopha.2025.118637","volume":"192","author":"S Gazova","year":"2025","unstructured":"Gazova S, Klena L, Galvankova K, Babula P, Krizanova O. Role of adrenergic receptors and their blocking in cancer research. Biomed Pharmacother. 2025;192:118637.","journal-title":"Biomed Pharmacother"},{"key":"2278_CR196","doi-asserted-by":"publisher","DOI":"10.3390\/ph13060105","author":"R Peixoto","year":"2020","unstructured":"Peixoto R, Pereira M, Oliveira M. Beta-blockers and cancer: where are we? Pharmaceuticals (Basel). 2020. https:\/\/doi.org\/10.3390\/ph13060105.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2278_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1325050","author":"R Massalee","year":"2024","unstructured":"Massalee R, Cao X. Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies. Front Pharmacol. 2024;14:1325050. https:\/\/doi.org\/10.3389\/fphar.2023.1325050","journal-title":"Front Pharmacol"},{"issue":"5","key":"2278_CR198","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.124.22821","volume":"81","author":"G Mancia","year":"2024","unstructured":"Mancia G, et al. Rationale for the Inclusion of \u03b2-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines. Hypertension. 2024;81(5):1021\u201330.","journal-title":"Hypertension"},{"issue":"21","key":"2278_CR199","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.123.065017","volume":"148","author":"K Seo","year":"2023","unstructured":"Seo K, et al. Improved cardiac performance and decreased arrhythmia in hypertrophic cardiomyopathy with non\u2013\u03b2-blocking R-enantiomer carvedilol. Circulation. 2023;148(21):1691\u2013704.","journal-title":"Circulation"},{"issue":"6","key":"2278_CR200","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.122.19020","volume":"79","author":"G Mancia","year":"2022","unstructured":"Mancia G, et al. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology\/European Society of Hypertension Guidelines. Hypertension. 2022;79(6):1153\u201366.","journal-title":"Hypertension"},{"issue":"9","key":"2278_CR201","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41388-022-02584-4","volume":"42","author":"P Jayachandran","year":"2023","unstructured":"Jayachandran P, et al. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. Oncogene. 2023;42(9):627\u201337.","journal-title":"Oncogene"},{"key":"2278_CR202","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400725RR","author":"S Cavalu","year":"2024","unstructured":"Cavalu S, et al. The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: extending beyond cardiovascular disorders. FASEB J. 2024;38(13):e23813. https:\/\/doi.org\/10.1096\/fj.202400725RR","journal-title":"FASEB J"},{"key":"2278_CR203","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009613","author":"TR Reid","year":"2024","unstructured":"Reid TR, et al. TGF-\u03b2 trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance. J Immunother Cancer. 2024;12(10):e009613. https:\/\/doi.org\/10.1136\/jitc-2024-009613","journal-title":"J Immunother Cancer"},{"key":"2278_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131642","author":"Y Leshem","year":"2024","unstructured":"Leshem Y, et al. The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab. Int J Cardiol. 2024;397:131642. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131642","journal-title":"Int J Cardiol"},{"key":"2278_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109383","author":"X Yan","year":"2022","unstructured":"Yan X, et al. Novel evidence for the prognostic impact of \u03b2-blockers in solid cancer patients receiving immune checkpoint inhibitors. Int Immunopharmacol. 2022;113(Pt A):109383. https:\/\/doi.org\/10.1016\/j.intimp.2022.109383","journal-title":"Int Immunopharmacol"},{"key":"2278_CR206","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112690","author":"SY Park","year":"2022","unstructured":"Park SY, et al. Role of AMPK in regulation of oxaliplatin-resistant human colorectal cancer. Biomedicines. 2022;10(11):2690. https:\/\/doi.org\/10.3390\/biomedicines10112690","journal-title":"Biomedicines"},{"issue":"10","key":"2278_CR207","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.3390\/cimb45100505","volume":"45","author":"BA Ikhmais","year":"2023","unstructured":"Ikhmais BA, et al. Investigating Carvedilol\u2019s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of \u03b2-Adrenergic Agonists. Curr Issues Mol Biol. 2023;45(10):7996\u20138012.","journal-title":"Curr Issues Mol Biol"},{"key":"2278_CR208","doi-asserted-by":"publisher","unstructured":"Eraslan S, Ayhan EC, Madsen MT, Sloan EK, G\u00f6genur I, Orhan A. Impact of beta-blockers on prognostic outcomes in solid cancers: a systematic review and meta-analysis. J Natl Cancer Inst. 2026. https:\/\/doi.org\/10.1093\/jnci\/djag082","DOI":"10.1093\/jnci\/djag082"},{"key":"2278_CR209","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1423502","author":"PGS Braga","year":"2024","unstructured":"Braga PGS, et al. \u03b2-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers. Front Pharmacol. 2024;15:1423502. https:\/\/doi.org\/10.3389\/fphar.2024.1423502","journal-title":"Front Pharmacol"},{"key":"2278_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041277","author":"M Zaborowska-Szmit","year":"2023","unstructured":"Zaborowska-Szmit M, et al. Beta blockers with statins may decrease all-cause mortality in patients with cardiovascular diseases and locally advanced unresectable non-small-cell lung cancer after chemoradiotherapy. Cancers. 2023;15(4):1277. https:\/\/doi.org\/10.3390\/cancers15041277","journal-title":"Cancers"},{"key":"2278_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93205-z","author":"X Liang","year":"2025","unstructured":"Liang X, et al. Beta-adrenergic receptor blockers improve survival in patients with advanced non-small cell lung cancer combined with hypertension undergoing radiotherapy. Sci Rep. 2025;15(1):10702. . https:\/\/doi.org\/10.1038\/s41598-025-93205-z","journal-title":"Sci Rep"},{"issue":"6","key":"2278_CR212","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2220\/biomedres.45.253","volume":"45","author":"M Tomihari","year":"2024","unstructured":"Tomihari M, Iwasaki M, Ishikawa M. Propranolol and landiolol inhibit cell proliferation enhanced by noradrenaline in human lung adenocarcinoma cells. Biomed Res. 2024;45(6):253\u20139.","journal-title":"Biomed Res"},{"key":"2278_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216337","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Longitudinal detection of subcategorized CD44v6\u2009+\u2009CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: a prospective, multi-center study. Cancer Lett. 2023;571:216337. https:\/\/doi.org\/10.1016\/j.canlet.2023.216337","journal-title":"Cancer Lett"},{"key":"2278_CR214","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149551","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Hematopoietic transcription factor GFI1 promotes anchorage independence by sustaining ERK activity in cancer cells. J Clin Invest. 2022;132(17):e149551. https:\/\/doi.org\/10.1172\/JCI149551","journal-title":"J Clin Invest"},{"key":"2278_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154409","author":"H Hao","year":"2022","unstructured":"Hao H, et al. Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4. Phytomedicine. 2022;106:154409. https:\/\/doi.org\/10.1016\/j.phymed.2022.154409","journal-title":"Phytomedicine"},{"issue":"1","key":"2278_CR216","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bja.2018.03.024","volume":"121","author":"A Yap","year":"2018","unstructured":"Yap A, et al. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth. 2018;121(1):45\u201357.","journal-title":"Br J Anaesth"},{"issue":"12","key":"2278_CR217","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.21037\/jtd-23-1098","volume":"15","author":"Y Lu","year":"2023","unstructured":"Lu Y, et al. Causal effect of beta-blockers on the risk of lung cancer: a Mendelian randomization study. J Thorac Disease. 2023;15(12):6651\u201360.","journal-title":"J Thorac Disease"},{"issue":"2","key":"2278_CR218","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jclinane.2013.10.004","volume":"26","author":"JP Cata","year":"2014","unstructured":"Cata JP, et al. Perioperative beta-blocker use and survival in lung cancer patients. J Clin Anesth. 2014;26(2):106\u201317.","journal-title":"J Clin Anesth"},{"key":"2278_CR219","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52194","author":"A Duarte Mendes","year":"2024","unstructured":"Duarte Mendes A, et al. Beta-adrenergic blockade in advanced non-small cell lung cancer patients receiving immunotherapy: a multicentric study. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.52194.","journal-title":"Cureus"},{"issue":"1","key":"2278_CR220","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10585-023-10258-y","volume":"41","author":"SG Nair","year":"2024","unstructured":"Nair SG, et al. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation. Clin Exp Metastasis. 2024;41(1):9\u201324.","journal-title":"Clin Exp Metastasis"},{"key":"2278_CR221","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2542334","author":"L Bezu","year":"2025","unstructured":"Bezu L, Kepp O, Kroemer G. Immuno-oncological effects of the \u03b12-adrenoceptor agonist dexmedetomidine. Oncoimmunology. 2025;14(1):2542334. https:\/\/doi.org\/10.1080\/2162402X.2025.2542334","journal-title":"Oncoimmunology"},{"issue":"7965","key":"2278_CR222","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","volume":"618","author":"J Zhu","year":"2023","unstructured":"Zhu J, et al. Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors. Nature. 2023;618(7965):607\u201315.","journal-title":"Nature"},{"issue":"7","key":"2278_CR223","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/bph.15731","volume":"179","author":"S Maccari","year":"2022","unstructured":"Maccari S, et al. \u03b1-Adrenoceptor stimulation attenuates melanoma growth in mice. Br J Pharmacol. 2022;179(7):1371\u201383.","journal-title":"Br J Pharmacol"},{"key":"2278_CR224","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030262","author":"D Silva","year":"2024","unstructured":"Silva D, et al. \u03b22-Adrenoceptor activation favor acquisition of tumorigenic properties in non-tumorigenic MCF-10A breast epithelial cells. Cells. 2024;13(3):262. https:\/\/doi.org\/10.3390\/cells13030262","journal-title":"Cells"},{"issue":"12","key":"2278_CR225","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/1940-6207.CAPR-13-0079","volume":"6","author":"MJ Szpunar","year":"2013","unstructured":"Szpunar MJ, et al. The Antidepressant Desipramine and \u03b12-Adrenergic Receptor Activation Promote Breast Tumor Progression in Association with Altered Collagen Structure. Cancer Prev Res. 2013;6(12):1262\u201372.","journal-title":"Cancer Prev Res"},{"issue":"16","key":"2278_CR226","first-page":"3500","volume":"20","author":"M Xia","year":"2016","unstructured":"Xia M, Ji NN, Duan ML, et al. Dexmedetomidine regulate the malignancy of breast cancer cells by activating \u03b12-adrenoceptor\/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2016;20(16):3500\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2278_CR227","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_376_19","author":"A Nair","year":"2020","unstructured":"Nair A, et al. Dexmedetomidine in cancer surgeries: present status and consequences with its use. Indian J Cancer. 2020;57(3):234-238. https:\/\/doi.org\/10.4103\/ijc.IJC_376_19","journal-title":"Indian J Cancer"},{"key":"2278_CR228","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02413-8","author":"J Yang","year":"2025","unstructured":"Yang J, et al. Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors. Mol Cancer. 2025;24(1):216. https:\/\/doi.org\/10.1186\/s12943-025-02413-8","journal-title":"Mol Cancer"},{"key":"2278_CR229","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0243","author":"E-H Leung","year":"2022","unstructured":"Leung E-H, et al. Novel anticancer strategy by targeting the gut microbial neurotransmitter signaling to overcome immunotherapy resistance. Antioxid Redox Signal. 2022. https:\/\/doi.org\/10.1089\/ars.2021.0243.","journal-title":"Antioxid Redox Signal"},{"key":"2278_CR230","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00835-6","author":"W Chen","year":"2025","unstructured":"Chen W, et al. Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. Biomark Res. 2025;13(1):125. https:\/\/doi.org\/10.1186\/s40364-025-00835-6","journal-title":"Biomark Res"},{"issue":"3","key":"2278_CR231","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.62347\/WMQV6643","volume":"14","author":"S-K Jang","year":"2024","unstructured":"Jang S-K. Duloxetine enhances the sensitivity of non-small cell lung cancer cells to EGFR inhibitors by REDD1-induced mTORC1\/S6K1 suppression. Am J Cancer Res. 2024;14(3):1087\u2013100.","journal-title":"Am J Cancer Res"},{"key":"2278_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155907","author":"X Bai","year":"2024","unstructured":"Bai X, et al. Exploring the potential of cryptochlorogenic acid as a dietary adjuvant for multi-target combined lung cancer treatment. Phytomedicine. 2024;132:155907. https:\/\/doi.org\/10.1016\/j.phymed.2024.155907","journal-title":"Phytomedicine"},{"issue":"11","key":"2278_CR233","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jtho.2022.07.007","volume":"17","author":"U Pastorino","year":"2022","unstructured":"Pastorino U, et al. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial. J Thorac Oncol. 2022;17(11):1276\u201386.","journal-title":"J Thorac Oncol"},{"key":"2278_CR234","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jconrel.2021.05.039","volume":"335","author":"M Shahriari","year":"2021","unstructured":"Shahriari M, et al. Self-targeted polymersomal co-formulation of doxorubicin, camptothecin and FOXM1 aptamer for efficient treatment of non-small cell lung cancer. J Controlled Release. 2021;335:369\u201388.","journal-title":"J Controlled Release"},{"key":"2278_CR235","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01748-5","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities. J Hematol Oncol. 2025;18(1):93. https:\/\/doi.org\/10.1186\/s13045-025-01748-5","journal-title":"J Hematol Oncol"},{"key":"2278_CR236","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02989-x","author":"Z Hu","year":"2024","unstructured":"Hu Z, et al. IL6-STAT3-C\/EBP\u03b2-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma. J Exp Clin Cancer Res. 2024;43(1):63. https:\/\/doi.org\/10.1186\/s13046-024-02989-x","journal-title":"J Exp Clin Cancer Res"},{"key":"2278_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682322","author":"L Xu","year":"2025","unstructured":"Xu L, et al. Neuro\u2013immune\u2013tumor axis in gliomas: a review of mechanisms, models, and translational opportunities. Front Immunol. 2025;16:1682322. https:\/\/doi.org\/10.3389\/fimmu.2025.1682322","journal-title":"Front Immunol"},{"key":"2278_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286986","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang J, Li F. Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment. Front Immunol. 2023;14:1286986. https:\/\/doi.org\/10.3389\/fimmu.2023.1286986","journal-title":"Front Immunol"},{"key":"2278_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127858","author":"S Qu","year":"2024","unstructured":"Qu S, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res. 2024;287:127858. https:\/\/doi.org\/10.1016\/j.micres.2024.127858","journal-title":"Microbiol Res"},{"key":"2278_CR240","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.947","author":"X Qian","year":"2022","unstructured":"Qian X, et al. Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer. Clin Transl Med. 2022;12(6):e947. https:\/\/doi.org\/10.1002\/ctm2.947","journal-title":"Clin Transl Med"},{"key":"2278_CR241","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58553-4","author":"R Preet","year":"2025","unstructured":"Preet R, et al. Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer. Nat Commun. 2025;16(1):3500. https:\/\/doi.org\/10.1038\/s41467-025-58553-4","journal-title":"Nat Commun"},{"key":"2278_CR242","doi-asserted-by":"crossref","unstructured":"Ma P-J, Wang M-M, Wang Y. Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy; 2022. p. 155.","DOI":"10.1016\/j.biopha.2022.113810"},{"key":"2278_CR243","doi-asserted-by":"publisher","unstructured":"Zhang X-W et al. Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR. Cell Death Dis, 2022;13(1):41. https:\/\/doi.org\/10.1038\/s41419-021-04485-y","DOI":"10.1038\/s41419-021-04485-y"},{"issue":"1","key":"2278_CR244","first-page":"176","volume":"13","author":"S Taheri Baghmisheh","year":"2023","unstructured":"Taheri Baghmisheh S, Wu YY, Wu JE, Hsu KF, Chen YL, Hong TM. CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV. Am J Cancer Res. 2023;13(1):176\u201389.","journal-title":"Am J Cancer Res"},{"key":"2278_CR245","doi-asserted-by":"publisher","unstructured":"Nie M et al. Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse. J Clin Invest, 2022;132(20):e160152. https:\/\/doi.org\/10.1172\/JCI160152","DOI":"10.1172\/JCI160152"},{"key":"2278_CR246","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04904-6","author":"J Peng","year":"2024","unstructured":"Peng J, et al. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma. J Transl Med. 2024;22(1):87. https:\/\/doi.org\/10.1186\/s12967-024-04904-6","journal-title":"J Transl Med"},{"issue":"6","key":"2278_CR247","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/02698811251326939","volume":"39","author":"C-F Kao","year":"2025","unstructured":"Kao C-F, et al. Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression. J Psychopharmacol. 2025;39(6):593\u2013602.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"2278_CR248","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-024-02997-x","volume":"43","author":"D de Miguel-Perez","year":"2024","unstructured":"de Miguel-Perez D, Ak M, Mamindla P, et al. Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024;43(1):81.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2278_CR249","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s11547-022-01569-3","volume":"127","author":"Y Fan","year":"2022","unstructured":"Fan Y, et al. Radiomics for prediction of response to EGFR-TKI based on metastasis\/brain parenchyma (M\/BP)-interface. Radiol Med 2022;127(12):1342\u201354. https:\/\/doi.org\/10.1007\/s11547-022-01569-3","journal-title":"Radiol Med"},{"key":"2278_CR250","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1373330","author":"J Xu","year":"2024","unstructured":"Xu J, et al. Development and validation of an MRI-based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer. Front Immunol. 2024;15:1373330. https:\/\/doi.org\/10.3389\/fimmu.2024.1373330","journal-title":"Front Immunol"},{"issue":"13","key":"2278_CR251","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1007\/s00259-025-07354-4","volume":"52","author":"C Wang","year":"2025","unstructured":"Wang C, et al. Development and validation of a radiogenomics prognostic model integrating PET\/CT radiomics and glucose metabolism-related gene signatures for non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2025;52(13):4924\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"2278_CR252","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11547-023-01676-9","volume":"128","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study. Radiol Med. 2023;128(9):1079\u201392.","journal-title":"Radiol Med"},{"issue":"6","key":"2278_CR253","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1109\/JBHI.2022.3156984","volume":"26","author":"E D\u2019Arnese","year":"2022","unstructured":"D\u2019Arnese E, et al. On the Automation of Radiomics-Based Identification and Characterization of NSCLC. IEEE J Biomedical Health Inf. 2022;26(6):2670\u20139.","journal-title":"IEEE J Biomedical Health Inf"},{"issue":"3","key":"2278_CR254","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","volume":"39","author":"S-H Jiang","year":"2019","unstructured":"Jiang S-H, et al. Neurotransmitters: emerging targets in cancer. Oncogene. 2019;39(3):503\u201315.","journal-title":"Oncogene"},{"key":"2278_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176860","author":"W Bian","year":"2024","unstructured":"Bian W, et al. Efficacy of GluN2B-containing NMDA receptor antagonist for antitumor and antidepressant therapy in non-small cell lung cancer. Eur J Pharmacol. 2024;980:176860. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176860","journal-title":"Eur J Pharmacol"},{"key":"2278_CR256","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jinorgbio.2017.11.014","volume":"179","author":"K Tian","year":"2018","unstructured":"Tian K, et al. Neuronal death\/apoptosis induced by intracellular zinc deficiency associated with changes in amino-acid neurotransmitters and glutamate receptor subtypes. J Inorg Biochem. 2018;179:54\u20139.","journal-title":"J Inorg Biochem"},{"issue":"6","key":"2278_CR257","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1007\/s11033-023-08432-2","volume":"50","author":"J Joshi","year":"2023","unstructured":"Joshi J, et al. An association of epidermal growth factor receptor mutation subtypes with prognostic prediction and site-specific recurrence in advanced stage lung cancer patients. Mol Biol Rep. 2023;50(6):5105\u201315.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"2278_CR258","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/jcb.27510","volume":"120","author":"H Tang","year":"2018","unstructured":"Tang H, et al. Interaction of estrogen receptor \u03b25 and interleukin 6 receptor in the progression of non\u2013small cell lung cancer. J Cell Biochem. 2018;120(2):2028\u201338.","journal-title":"J Cell Biochem"},{"key":"2278_CR259","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100557","author":"C Arora","year":"2024","unstructured":"Arora C, et al. The landscape of cancer-rewired GPCR signaling axes. Cell Genom. 2024;4(5):100557. https:\/\/doi.org\/10.1016\/j.xgen.2024.100557","journal-title":"Cell Genom"},{"key":"2278_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1572802","author":"W Chen","year":"2025","unstructured":"Chen W, Zhou A, Zhou Y. Bispecific antibody for lung cancer: mechanisms and clinical insights. Front Immunol. 2025;16:1572802. https:\/\/doi.org\/10.3389\/fimmu.2025.1572802","journal-title":"Front Immunol"},{"key":"2278_CR261","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105691","author":"S Tomassini","year":"2022","unstructured":"Tomassini S, et al. Lung nodule diagnosis and cancer histology classification from computed tomography data by convolutional neural networks: a survey. Comput Biol Med. 2022;146:105691. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105691","journal-title":"Comput Biol Med"},{"key":"2278_CR262","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02246-5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Hijacking of the nervous system in cancer: mechanism and therapeutic targets. Mol Cancer. 2025;24(1):44. https:\/\/doi.org\/10.1186\/s12943-025-02246-5","journal-title":"Mol Cancer"},{"issue":"11","key":"2278_CR263","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s43018-020-00146-9","volume":"1","author":"IE Demir","year":"2020","unstructured":"Demir IE, et al. Future directions in preclinical and translational cancer neuroscience research. Nat Cancer. 2020;1(11):1027\u201331.","journal-title":"Nat Cancer"},{"issue":"6","key":"2278_CR264","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrc.2016.38","volume":"16","author":"M Amit","year":"2016","unstructured":"Amit M, Na\u2019ara S, Gil Z. Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016;16(6):399\u2013408.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"2278_CR265","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","volume":"12","author":"IE Demir","year":"2015","unstructured":"Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer. Nat Reviews Gastroenterol Hepatol. 2015;12(11):649\u201359.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"46","key":"2278_CR266","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1039\/D4AY01685H","volume":"16","author":"T Hu","year":"2024","unstructured":"Hu T, Han F, An Z. Comprehensive profiling of serum glycosphingolipids to discover the diagnostic biomarkers of lung cancer and uncover the variation of glycosphingolipid networks in different lung cancer subtypes. Anal Methods. 2024;16(46):7873\u201387.","journal-title":"Anal Methods"},{"key":"2278_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00801-x","author":"J Fu","year":"2021","unstructured":"Fu J, et al. [99mTc]Tc-Galacto-RGD2 integrin \u03b1v\u03b23-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data. EJNMMI Res. 2021;11(1):59. https:\/\/doi.org\/10.1186\/s13550-021-00801-x","journal-title":"EJNMMI Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02278-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:02:04Z","timestamp":1786946524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":267,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02278-1","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this review that did not involve patients or patient data.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"299"}}